Stocks股票 / Health Care / REGN
Regeneron Pharmaceuticals · Health Care
REGN US listed · USD美股 · 美元
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.Regeneron Pharmaceuticals, Inc. 是一家美国生物技术公司，总部位于纽约州威斯特彻斯特县。
Mixed profile混合特征
Health Care
S&P 500标普500
$672.15
-$4.54 · -0.67%
52w low52周低 $532high高 $821
Neutral — no clear edge中性 — 无明显优势
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 607.93.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 607.93 下方。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
60
Elevated偏高
vs 50-day average相对50日均线
+4.3% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
-4.5% below下方
Long trend down长期向下
Volatility波动率
22th percentile第22百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-08-0718days to go天后公布
Estimates being cut预期下调
Post-earnings drift: -16.7% (20d)财报后漂移：-16.7%（20日）
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 11.0%
Earnings per share每股收益
5-yr growth5年复合增速 6.3%
Free cash flow自由现金流
Operating margin营业利润率
24.9%
Net margin净利率
31.4%
FCF margin自由现金流利润率
34.7%
Balance-sheet quality财务体质 4/7
Return on equity股本回报率 14%
Clean稳健
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.27
Current ratio流动比率4.13
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$3.4B
Stock-based comp股权薪酬$993.7M
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
News新闻
2 recent stories — mixed2 篇最新报道，多空参半
Sector / Theme行业/主题
Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.25%
Expected weekly move预期周波动
±5.04%
Gamma flip伽玛翻转位
$635
25d risk reversal25d风险逆转
-1.9%
Skew: balanced偏斜：balanced
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$9.2M net (0 buyers, 5 sellers)-$9.2M 净值（0 买家，5 卖家）
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Scion Asset Mgmt (Burry) | A | exitexit | 0.0% | 2025-09-30 |
Signal history信号历史
engine events引擎事件
BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY. A daily bottoming setup is forming (swing low in, momentum turned up) — but the higher timeframes haven't confirmed it: the bigger picture is still bearish (weekly momentum curling up; investor cycle overdue; last cycle left-translated (topped early)). This is an UNCONFIRMED TURN, not a confirmed buy. Weekly confirmation lags price, so this exact reading covers BOTH bounces that fail AND the first leg of a genuine new cycle — you can't tell which in real time, so treat it as a risk/size signal, not a direction call. Measured: weekly-unconfirmed bottoming setups held the low ~49% of the time vs ~68% once the weekly turns up. Last cycle was left-translated (topped early) — a bearish structural tell高风险 · 仅限灵活操作。正在形成日线筑底形态（摆动低点已现、动量转向上行）——但更高周期尚未确认：大局仍偏空（周线动量开始上翘；投资者周期已逾期；上一周期左移（见顶偏早））。这是「未确认转向」，并非已确认的买入。周线确认滞后于价格，因此同样的读数既涵盖最终失败的反弹，也涵盖真正新周期的第一段——实时无法判定属于哪一种，故应将其视为风险/仓位信号，而非方向判断。实测：周线未确认的筑底形态约 49% 守住低点，周线转向后升至约 68%。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Jul 9, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Jun 22, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 15, 2026
DOWNTREND → NEARING A LOW下跌趋势 → 接近低点
GET READY准备
Jun 12, 2026
Death cross on REGNREGN 死叉
The 50-day average crossed below the 200-day — a slow, widely-watched bearish trend signal. $612.14.50日均线下穿200日均线 — 一个滞后但广受关注的看空趋势信号。$612.14。
Jun 8, 2026
UPTREND → DOWNTREND上涨趋势 → 下跌趋势
AVOID回避
Jun 8, 2026
REGN broke down vs the marketREGN 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $611.34.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$611.34。
Showing the last 15 of显示最近15条，共 88 signals条信号
Company profile公司档案
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.Regeneron Pharmaceuticals, Inc. 是一家美国生物技术公司，总部位于纽约州威斯特彻斯特县。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Capital intensity rising
Recent news最新动态
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
GlobeNewswire Inc. · 2026-07-20
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
50/100 — middle of the pack居中
vs market, 3 months相对大盘（3个月）
16/100 — weaker than most弱于多数
vs market, 6 months相对大盘（6个月）
23/100 — weaker than most弱于多数
vs market, 12 months相对大盘（12个月）
57/100 — middle of the pack居中
Rank in sector行业内排名
#96 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +1.4% | -0.9% |
| 1 Month近1月 | +10.2% | -0.6% |
| 3 Months近3月 | -9.9% | +5.4% |
| 6 Months近6月 | -10.1% | +8.6% |
| Year to date年初至今 | -13.2% | +8.9% |
| 1 Year近1年 | +24.6% | +19.2% |
Trading information交易信息
Beta vs market贝塔
0.40
Volatility rank波动率分位
22th pctile
Off 52-week high距52周高点
-17.0%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $8.5B | $16.1B | $12.2B | $13.1B | $14.2B | $14.3B |
| EPS每股收益 | $30.52 | $71.97 | $38.22 | $34.77 | $38.34 | $41.48 |
| Free cash flow自由现金流 | $2.0B | $6.5B | $4.4B | $3.9B | $3.7B | $4.1B |
| Gross margin毛利率 | 95.3% | — | — | — | — | — |
| Net margin净利率 | 41.3% | 50.2% | 35.6% | 30.1% | 31.1% | 31.4% |
| FCF margin自由现金流利润率 | 23.6% | 40.6% | 36.3% | 29.5% | 25.8% | 28.4% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$14.3B
Net income净利润
$4.5B
Operating cash flow经营现金流
$5.0B
Total assets总资产
$40.6B
Shareholder equity股东权益
$31.3B
Long-term debt长期负债
$2.0B
Buybacks股票回购
$3.4B
Returns & growth回报与增长
Return on equity股本回报率
14.4%
Return on assets资产回报率
11.1%
Debt / assets负债/资产
4.9%
Profit growth利润增速
+2.1%
Asset growth资产增速
+7.4%
Accounting quality checks会计质量检查
- Earnings quality: accruals elevated vs peers (earnings lean on non-cash items)盈利质量：应计利润高于同业（盈利依赖非现金项目）
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: leverage unremarkable资产负债表：杠杆水平一般
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
60
RSI (2-day)RSI（2日）
43
vs 20-day average相对20日均线
+3.6%
vs 50-day average相对50日均线
+4.3%
vs 200-day average相对200日均线
-4.5%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum up动能向上
Weekly周线
momentum down — turning up soon动能向下——接近转强
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
73/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
9
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
-0.2%
Net upgrades, 30 days净上调（30天）
+1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Options — full detail期权持仓 — 完整明细
Dealer positioning map做市商持仓地图
Call wall看涨期权墙
$700
Put wall看跌期权墙
$600
Gamma flip伽玛翻转位
$635
Upside magnet上方磁吸位
$700
Downside magnet下方磁吸位
$650
Net dealer gamma做市商净伽玛
+$0.0B
Distance to flip距翻转位
+5.6%
Walls and magnets are strikes with heavy open interest — price often slows or gravitates there.期权墙与磁吸位是未平仓集中的行权价 — 价格常在附近减速或被吸引。
Volatility pricing波动率定价
Implied volatility (30d)隐含波动率（30天）
0%
25-delta risk reversal25-delta风险逆转
-1.9%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Scion Asset Mgmt (Burry) | A | Exited清仓 | 0.0% | $113M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
0 : 1
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2023-12-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2024-02-14', 'holders_series': [1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0]}{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2023-12-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2024-02-14', 'holders_series': [1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$9.2M
Insider buyers vs sellers内部人买家vs卖家
0 : 5
Days to cover回补天数
2.9
Short interest change空头变化
+5.8%
Recent fund flows近期基金流向
Roundhill GLP-1 & Weight LossRoundhill GLP-1 & Weight Loss
trimming减持
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。